Anaxomics is and innovative company that from its very beginning is committed to the advancement of science. Anaxomics has participated as a partner in several Research Projects applying its innovative technology.
TRANSAUTOPHAGY European Network of Multidisciplinary Research and Translation of Autophagy knowledge
Learn more about Research TRANSAUTOPHAGY
MICROBIOTA Identification of novel ingredients modulators of human and animal microbiota using industrial biotechnology, omics technologies and big data technologies
Learn more about Research MICROBIOTA
DIALCAT Diabetes as Alzheimer accelerator
Learn more about Research DIALCAT
INDUSTRIAL DOCTORATE Industrial Doctorate programme: Identification of new therapeutic strategies in chronic lymphocytic leukemia
Learn more about Research INDUSTRIAL DOCTORATE
SYSTEMAGE: Early warning signals of ageing in human stem cells and age-related disorders
Learn more about Research SYSTEMAGE
TRIGGER: King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies
Learn more about Research TRIGGER
Indox: Optimized oxidoreductases for medium and large scale industrial biotransformations
Learn more about Research Indox
CombiMS: A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis
Learn more about Research CombiMS
VISION: Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments
Learn more about Research VISION
RAPID: Rheumatoid Arthritis and Periodontal Inflammatory Disease
Learn more about Research RAPID
NBDS: Anaxomics and Nucro-Technics will develop a joint research project in the field of new safety biomarkers.
Learn more about Research NBDS
Gums&Joints: Protein citrullination as a link between periodontal diseases and rheumatoid arthritis (RA) and target for development of novel drugs to treat RA
Learn more about Research Gums&Joints
DYNAPUMP NEO: Development of a biotechnology application to facilitate individualized drug therapy in neonatology.
Learn more about DYNAPUMP
AntipathoGN: Identification and Validation of Novel Drug Targets in Gram-Negative Bacteria by Global Search: A Trans-System Approach.
Learn more about Research AntiPathoGN